Quarterly report · Q2

Period2022-12-01 → 2023-05-31
Filed2023-07-10
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥4.2bn2022-12-01 → 2023-05-31Cons.Net sales
Revenue¥8.4bn2021-12-01 → 2022-11-30Cons.Net sales (5-year summary)
Revenue¥3.9bn2021-12-01 → 2022-05-31Cons.Net sales
Operating income¥156m2022-12-01 → 2023-05-31Cons.Operating income
Operating income¥226m2021-12-01 → 2022-05-31Cons.Operating income
Ordinary income¥156m2022-12-01 → 2023-05-31Cons.Ordinary income
Ordinary income¥303m2021-12-01 → 2022-11-30Cons.Ordinary income loss (5-year summary)
Ordinary income¥235m2021-12-01 → 2022-05-31Cons.Ordinary income
Profit before tax¥155m2022-12-01 → 2023-05-31Cons.Income before income taxes
Profit before tax¥234m2021-12-01 → 2022-05-31Cons.Income before income taxes
Net income (owners)¥121m2022-12-01 → 2023-05-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥219m2021-12-01 → 2022-11-30Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥179m2021-12-01 → 2022-05-31Cons.Profit loss attributable to owners of parent
Net income¥121m2022-12-01 → 2023-05-31Cons.Profit loss
Net income¥179m2021-12-01 → 2022-05-31Cons.Profit loss
Total assets¥8.0bnat 2023-05-31Cons.Assets
Total assets¥8.3bnat 2022-11-30Cons.Assets
Total assets¥7.8bnat 2022-05-31Cons.Total assets (5-year summary)
Total liabilities¥5.5bnat 2023-05-31Cons.Liabilities
Total liabilities¥5.9bnat 2022-11-30Cons.Liabilities
Net assets / equity¥2.5bnat 2023-05-31Cons.Net assets
Net assets / equity¥2.4bnat 2022-11-30Cons.Net assets
Net assets / equity¥2.4bnat 2022-05-31Cons.Net assets (5-year summary)
Cash and deposits¥999mat 2023-05-31Cons.Cash and deposits
Cash and deposits¥911mat 2022-11-30Cons.Cash and deposits
Cash & equivalents¥999mat 2023-05-31Cons.Cash and cash equivalents
Cash & equivalents¥911mat 2022-11-30Cons.Cash and cash equivalents
Cash & equivalents¥984mat 2022-05-31Cons.Cash and cash equivalents
Cash & equivalents¥1.3bnat 2021-11-30dCons.Cash and cash equivalents
Operating cash flow¥223m2022-12-01 → 2023-05-31Cons.Net cash provided by used in operating activities
Operating cash flow−¥21m2021-12-01 → 2022-11-30Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow−¥124m2021-12-01 → 2022-05-31Cons.Net cash provided by used in operating activities
Investing cash flow−¥217m2022-12-01 → 2023-05-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥243m2021-12-01 → 2022-11-30Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥121m2021-12-01 → 2022-05-31Cons.Net cash provided by used in investment activities
Financing cash flow¥80m2022-12-01 → 2023-05-31Cons.Net cash provided by used in financing activities
Financing cash flow−¥162m2021-12-01 → 2022-11-30Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥104m2021-12-01 → 2022-05-31Cons.Net cash provided by used in financing activities
EPS (basic)¥99.172022-12-01 → 2023-05-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥65.392023-03-01 → 2023-05-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥179.752021-12-01 → 2022-11-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥147.062021-12-01 → 2022-05-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥68.822022-03-01 → 2022-05-31dCons.Basic earnings loss per share (5-year summary)
Equity ratio31.1%at 2023-05-31Cons.Equity to asset ratio (5-year summary)
Equity ratio29.0%at 2022-11-30Cons.Equity to asset ratio (5-year summary)
Equity ratio30.6%at 2022-05-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 18
SegmentItemPeriodValue
jpcrp040300-q2r_E01006-000Pharmaceutical Productsreportable segmentrevenue2022-12-01 → 2023-05-31¥4.2bn
jpcrp040300-q2r_E01006-000Pharmaceutical Productsreportable segmentrevenue external2022-12-01 → 2023-05-31¥4.2bn
jpcrp040300-q2r_E01006-000Pharmaceutical Productsreportable segmentsegment profit2022-12-01 → 2023-05-31¥141m
jpcrp040300-q2r_E01006-000Real Estate Leasingreportable segmentrevenue2022-12-01 → 2023-05-31¥19m
jpcrp040300-q2r_E01006-000Real Estate Leasingreportable segmentrevenue external2022-12-01 → 2023-05-31¥19m
jpcrp040300-q2r_E01006-000Real Estate Leasingreportable segmentsegment profit2022-12-01 → 2023-05-31¥15m
Total Of Reportable Segments And Otherssegment totalrevenue2022-12-01 → 2023-05-31¥4.2bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-12-01 → 2023-05-31¥4.2bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-12-01 → 2023-05-31¥156m
jpcrp040300-q2r_E01006-000Pharmaceutical Productsreportable segmentrevenue2021-12-01 → 2022-05-31¥3.9bn
jpcrp040300-q2r_E01006-000Pharmaceutical Productsreportable segmentrevenue external2021-12-01 → 2022-05-31¥3.9bn
jpcrp040300-q2r_E01006-000Pharmaceutical Productsreportable segmentsegment profit2021-12-01 → 2022-05-31¥211m
jpcrp040300-q2r_E01006-000Real Estate Leasingreportable segmentrevenue2021-12-01 → 2022-05-31¥19m
jpcrp040300-q2r_E01006-000Real Estate Leasingreportable segmentrevenue external2021-12-01 → 2022-05-31¥19m
jpcrp040300-q2r_E01006-000Real Estate Leasingreportable segmentsegment profit2021-12-01 → 2022-05-31¥15m
Total Of Reportable Segments And Otherssegment totalrevenue2021-12-01 → 2022-05-31¥3.9bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-12-01 → 2022-05-31¥3.9bn
Total Of Reportable Segments And Otherssegment totalsegment profit2021-12-01 → 2022-05-31¥226m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 469
ItemContextValueUnit
Interest expenses noePrior1YTDDuration8797000JPY
Interest expenses noeCurrentYTDDuration8868000JPY
Other noePrior1YTDDuration45000JPY
Other noeCurrentYTDDuration36000JPY
Non operating expensesPrior1YTDDuration8843000JPY
Non operating expensesCurrentYTDDuration8904000JPY
Ordinary incomePrior1YTDDuration235477000JPY
Ordinary incomeCurrentYTDDuration156261000JPY
Loss on retirement of noncurrent assets elPrior1YTDDuration1736000JPY
Loss on retirement of noncurrent assets elCurrentYTDDuration1064000JPY
Extraordinary lossPrior1YTDDuration1736000JPY
Extraordinary lossCurrentYTDDuration1064000JPY
Income before income taxesPrior1YTDDuration233741000JPY
Income before income taxesCurrentYTDDuration155197000JPY
Income taxes currentPrior1YTDDuration50834000JPY
Income taxes currentCurrentYTDDuration26666000JPY
Income taxes deferredPrior1YTDDuration3857000JPY
Income taxes deferredCurrentYTDDuration7797000JPY
Income taxesPrior1YTDDuration54692000JPY
Income taxesCurrentYTDDuration34464000JPY
Profit lossPrior1YTDDuration179048000JPY
Profit lossCurrentYTDDuration120732000JPY
Profit loss attributable to non controlling interestsPrior1YTDDuration-JPY
Profit loss attributable to non controlling interestsCurrentYTDDuration-JPY
Profit loss attributable to owners of parentPrior1YTDDuration179048000JPY
Profit loss attributable to owners of parentCurrentYTDDuration120732000JPY
Profit lossPrior1YTDDuration179048000JPY
Profit lossCurrentYTDDuration120732000JPY
Valuation difference on available for sale securities net of tax ociPrior1YTDDuration-5428000JPY
Valuation difference on available for sale securities net of tax ociCurrentYTDDuration6107000JPY
Foreign currency translation adjustment net of tax ociPrior1YTDDuration13316000JPY
Foreign currency translation adjustment net of tax ociCurrentYTDDuration3090000JPY
Other comprehensive incomePrior1YTDDuration7887000JPY
Other comprehensive incomeCurrentYTDDuration9197000JPY
Comprehensive incomePrior1YTDDuration186936000JPY
Comprehensive incomeCurrentYTDDuration129929000JPY
Comprehensive income attributable to owners of the parentPrior1YTDDuration186936000JPY
Comprehensive income attributable to owners of the parentCurrentYTDDuration129929000JPY
Comprehensive income attributable to non controlling interestsPrior1YTDDuration-JPY
Comprehensive income attributable to non controlling interestsCurrentYTDDuration-JPY
Income before income taxesPrior1YTDDuration233741000JPY
Income before income taxesCurrentYTDDuration155197000JPY
Depreciation and amortization ope cfPrior1YTDDuration195400000JPY
Depreciation and amortization ope cfCurrentYTDDuration201810000JPY
Increase decrease in allowance for doubtful accounts ope cfPrior1YTDDuration-89000JPY
Increase decrease in allowance for doubtful accounts ope cfCurrentYTDDuration-329000JPY
Increase decrease in net defined benefit liability ope cfPrior1YTDDuration-256000JPY
Increase decrease in net defined benefit liability ope cfCurrentYTDDuration-25210000JPY
Increase decrease in provision for directors bonuses ope cfPrior1YTDDuration-13800000JPY
Increase decrease in provision for directors bonuses ope cfCurrentYTDDuration-11100000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2022-11-30pass
balance sheet identityconsolidated 2023-05-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-11-30pass
statement vs summary · net assetsconsolidated 2023-05-31pass
statement vs summary · net income attributable to parentconsolidated 2021-12-01/2022-05-31pass
statement vs summary · net income attributable to parentconsolidated 2022-12-01/2023-05-31pass
statement vs summary · operating cash flowconsolidated 2021-12-01/2022-05-31pass
statement vs summary · operating cash flowconsolidated 2022-12-01/2023-05-31pass
statement vs summary · revenueconsolidated 2021-12-01/2022-05-31pass
statement vs summary · revenueconsolidated 2022-12-01/2023-05-31pass
statement vs summary · total assetsconsolidated 2022-11-30pass
statement vs summary · total assetsconsolidated 2023-05-31pass